SUN15 Phenotyping Hidradenitis Suppurativa (HS): Findings of a Collaborative Artificial Intelligence (AI) Initiative
DESCRIPTION
This session will present how innovative AI modeling can identify a distinct hidradenitis suppurativa (HS) phenotype comprising data elements from patients' health histories. This phenotype can distinguish HS patients who may otherwise remain undiagnosed from the broader population, providing clinical insight and the potential for reduced time to diagnosis and treatment. Such innovations can be applied to help recognize other diseases, allowing earlier access to treatment, and ultimately decrease patient suffering.
LEARNING OBJECTIVES
Demonstrate how a heterogeneous open claims data source augmented with EHR data, can be used to identify patients with hidradenitis suppurativa (HS).
Examine how AI can be used to isolate disease profiles to identify patients for early intervention and targeted treatment.
Compare the predictors of HS diagnosis identified by AI with the existing literature and our current understanding of the disease
SCHEDULE
7:30 AM
Introduction to DataDerm, Patient Finder, and our AI project
Steven Daniel Daveluy, MD, FAAD
7:40 AM
The Problem of Underdiagnosis in Hidradenitis Suppurativa
Julia Mhlaba Riley, MD, FAAD
7:55 AM
Patient Finder-How and why is it able to find HS patients?
Joseph Zabinski, PhD
8:10 AM
Lessons learned from patient finder and how to utilize them to help patients with HS
Daniel Brian Eisen, MD, FAAD
8:25 AM
Question and Answer
DIRECTOR
Steven Daniel Daveluy, MD, FAAD
Wayne State University
SPEAKERS
Daniel Brian Eisen, MD, FAAD
University of California, Davis
Julia Mhlaba Riley, MD, FAAD
Northwestern Feinberg School of Medicine
Joseph Zabinski, PhD
DISCLOSURES
Steven Daniel Daveluy, MD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Incyte – Advisory Board(Honoraria); Insmed – Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Investigator(Grants/Research Funding); Novartis – Speaker(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); UCB – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Honoraria);
Daniel Brian Eisen, MD, FAAD
No financial relationships exist with ineligible companies.
Julia Mhlaba Riley, MD, FAAD
AbbVie – Investigator(Fees); Incyte Corporation – Investigator(Fees); MoonLake Immunotherapeutics – Investigator(Fees); Novartis – Investigator(Fees); UCB – Advisory Board(Fees);
Joseph Zabinski, PhD
No financial relationships exist with ineligible companies.